Cannabis Industry News
A collection of Cannabis latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Cannabis is not an effective treatment for common mental health conditions, says review
Cannabis is not an effective treatment for common mental health conditions despite the global surge in patients using it for that purpose, a review has found. Researchers concluded there was “very little evidence for its efficacy” in…
Medical cannabis isn't an effective treatment for anxiety, depression or PTSD, new research shows
People frequently use medical cannabis to treat anxiety, depression and PTSD, but two new reviews show there is little evidence that it works Join Our Community of Science Lovers! I agree my information will be processed in accordance with the…
Landmark study finds cannabis not effective for depression, anxiety
The largest ever review of medical cannabis trials found no evidence that it was effective in treating anxiety, depression or post-traumatic stress disorder, despite an explosion in the number of prescriptions being written each year to treat the…
San Francisco Leaders Hope to Spark City's Cannabis Scene | KQED
Failed to save article Please try again The sale of cannabis, prepared food, coffee and live entertainment — all in one place — has been legal in California for over a year. But while San Francisco has long been marijuana-friendly…
Will Pennsylvania finally legalize recreational cannabis?
HARRISBURG, Pa. — The debate over recreational cannabis continues in Pennsylvania, nearly 10 years after it was legalized for medical use. Pennsylvania Gov. Josh Shapiro highlighted his administration's support for the legalization of…
Survey: Most Massachusetts residents unaware of cannabis mental health risks
Massachusetts survey shows most residents unaware of cannabis mental health risks State data shows only 1 in 5 residents know regular marijuana use can increase the risk of psychosis and schizophrenia HERE IN MASSACHUSETTS. THAT'S RIGHT. ERIKA.
Does medicinal cannabis work for depression, anxiety or PTSD? Our study says there's no evidence
The number of Australians using medicinal cannabis has surged over the past five years. Around 700,000 Australians have used cannabis for their health in the past year. And since 2022, medicinal cannabis sales have increased four-fold. But the…
Cannabis Stocks To Keep An Eye On - March 16th
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations Tilray Brands, Canopy Growth, SNDL, Cronos Group, Aurora Cannabis, High Tide, and Quantum Biopharma are the seven Cannabis stocks to watch today, according to MarketBeat's…
Scientists debunk claims of marijuana as anxiety, mental health treatment
(CNN) — Using medical or recreational marijuana to ease symptoms of numerous mental health conditions doesn't work, according to two new analyses of existing gold-standard research. Medical marijuana includes products with cannabidiol, or…
Young/Middle-Aged Drug Users Risk Stroke
Posted March 16, 2026 | Reviewed by Michelle Quirk A new study covering 100 million people links strokes with cocaine, methamphetamine, and cannabis use. For people under 55, stroke risk nearly triples with amphetamine/methamphetamine, with cocaine…
The $300 a week medicine Daniel feels better without
There is no evidence medicinal cannabis is effective for treating anxiety, depression and PTSD, a new study has found, despite hundreds of thousands of Australians being prescribed the products to treat mental health conditions. Prescriptions for…
Curaleaf Announces Participation in the 38th Annual ROTH Conference
Conference will Feature Fireside Chat with Curaleaf Chairman and CEO Boris Jordan STAMFORD, Conn., March 17, 2026 /CNW/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ('Curaleaf' or the 'Company'), a leading international provider of…
Will Tilray Brands' Diversification Strategy Pay Off for Investors?
Expanding into new segments can present a business and its investors with more plentiful growth opportunities. It can also be an effective way to be less dependent on a particular market or industry. For years, Tilray Brands (TLRY +0.94%) and other…
Tilray: Big Bet On Beverages (Rating Upgrade) (NASDAQ:TLRY)
Tilray (TLRY) shares have declined 23% in 2026, reflecting investor skepticism despite recent strategic moves. Q2 results showed net revenue growth and improved losses, but gross margins fell to 26% due to beverage and sales mix. The BrewDog…
BrewDog US bars to be bought by firm behind UK rescue deal
News from The City, market updates plus comment and analysis from our business desk I would like to be emailed about offers, event and updates from Evening Standard. Read our privacy notice. Tilray Brands has agreed to buy some of BrewDog's US…
Receive a Daily briefing on Cannabis Industry News
Get Started